Set Sail and Forge Ahead! SpaceGen Successfully Concludes MEDICA 2023 in Dusseldorf, Germany

Set Sail and Forge Ahead! SpaceGen Successfully Concludes MEDICA 2023 in Dusseldorf, Germany

In this picturesque time of the year, with falling petals, we once again encounter you. From November 13th to 16th, as the global benchmark for the development of the medical industry, the international medical exhibition, MEDICA 2023, was successfully held in Dusseldorf, Germany.

As an "old friend" of MEDICA, SpaceGen, along with its star products, met with overseas friends once again on the picturesque banks of the Rhine, engaging in discussions about the new blueprint for precision treatment and exploring the latest research achievements in the medical industry.

As is well known, MEDICA, the International Trade Fair for Hospital and Medical Equipment in Dusseldorf, Germany, is a world-renowned comprehensive medical exhibition. MEDICA, with its irreplaceable scale and influence, ranks first among global medical trade fairs. Every year, more than 5,000 companies from over 130 international and regional entities participate, with 80% coming from countries outside Germany.

At the MEDICA exhibition, participants from different countries and regions flocked in, stopping to visit. SpaceGen engaged in in-depth dialogues with global partners, actively listening to the voices of the world. This exhibition not only showcased the latest product achievements to the world, laying the foundation for further opening up overseas markets but also demonstrated SpaceGen's continuous efforts in the global market and its determination to firmly advance its global strategic layout.

SpaceGen has always adhered to the principles of "Quality First, Reputation Paramount, Management Fundamental, and Service Sincere" as the guideline for sustainable development. Currently, SpaceGen has obtained CE-IVD certification for 22 products from the European Union. These products cover various fields, including early cancer screening, drug guidance, prognosis monitoring, and companion diagnostics.

Every appearance is a buildup of strength, and we express gratitude to every customer for their trust and support in SpaceGen. In the future, SpaceGen will continue to adhere to its global development strategy, focus on the research and development of tumor genetic products, further promote industry optimization and upgrading, steadfastly move forward on the path of high-quality sustainable development, and contribute to the global medical and health cause.